Related Experiment Video
Updated: Aug 9, 2026

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein
Published on: January 13, 2026
"Recovery" vena cava filter: experience in 96 patients
Sanjeeva P Kalva1, Christos A Athanasoulis, Chieh-Min Fan
1Department of Radiology, Massachusetts General Hospital, Boston, MA, USA. skalva@partners.org
The Recovery(TM) inferior vena cava (IVC) filter showed structural weakness, leading to IVC penetration and deployment issues. While no fatal pulmonary embolism occurred, these complications necessitate caution with this IVC filter.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Medical Device Safety
Background:
- Inferior vena cava (IVC) filters are used to prevent pulmonary embolism (PE) in patients with deep vein thrombosis (DVT) or contraindications to anticoagulation.
- The Recovery(TM) filter is one such device, and its clinical performance requires ongoing evaluation.
Purpose of the Study:
- To assess the clinical safety and efficacy of the Recovery(TM) IVC filter.
- To evaluate filter-related complications, including deployment, retrieval, and long-term integrity.
Main Methods:
- Retrospective evaluation of clinical and imaging data from 96 patients who received the Recovery(TM) IVC filter.
- Analysis of computed tomography (CT) scans for filter placement, complications, and pulmonary embolism (PE).
- Assessment of filter retrieval success rates and associated complications.
Main Results:
- The Recovery(TM) filter was successfully deployed in 96 patients.
- Filter retrieval was successful in 82% of attempted cases, with complications like IVC thrombus and intimal tear.
- Imaging revealed IVC penetration by filter arms in 11 patients, component fracture in 3, and asymmetric leg deployment in 12.
- One patient experienced PE post-retrieval, and one developed IVC thrombus.
- No filter migration or caval occlusion was observed.
Conclusions:
- The Recovery(TM) IVC filter is associated with structural weakness, high rates of IVC wall penetration, and asymmetric deployment.
- Despite these findings, no fatal pulmonary embolism was recorded in the study cohort.
- Further investigation and potential device redesign are warranted to address identified safety concerns.
More Related Videos
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Hemodialysis I: Introduction
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
